Literature DB >> 26941367

Impact of Pre-analytic Blood Sample Collection Factors on Metabolomics.

Mary K Townsend1, Ying Bao1, Clary B Clish2, Shelley S Tworoger1,3, Elizabeth M Poole1, Kimberly A Bertrand4, Peter Kraft3, Brian M Wolpin5,6.   

Abstract

BACKGROUND: Many epidemiologic studies are using metabolomics to discover markers of carcinogenesis. However, limited data are available on the influence of pre-analytic blood collection factors on metabolite measurement.
METHODS: We quantified 166 metabolites in archived plasma from 423 Health Professionals Follow-up Study and Nurses' Health Study participants using liquid chromatography-tandem mass spectrometry (LC-MS). We compared multivariable-adjusted geometric mean metabolite LC-MS peak areas across fasting time, season of blood collection, and time of day of blood collection categories.
RESULTS: The majority of metabolites (160 of 166 metabolites) had geometric mean peak areas that were within 15% comparing samples donated after fasting 9 to 12 versus ≥13 hours; greater differences were observed in samples donated after fasting ≤4 hours. Metabolite peak areas generally were similar across season of blood collection, although levels of certain metabolites (e.g., bile acids and purines/pyrimidines) tended to be different in the summer versus winter months. After adjusting for fasting status, geometric mean peak areas for bile acids and vitamins, but not other metabolites, differed by time of day of blood collection.
CONCLUSION: Fasting, season of blood collection, and time of day of blood collection were not important sources of variability in measurements of most metabolites in our study. However, considering blood collection variables in the design or analysis of studies may be important for certain specific metabolites, particularly bile acids, purines/pyrimidines, and vitamins. IMPACT: These results may be useful for investigators formulating analysis plans for epidemiologic metabolomics studies, including determining which metabolites to a priori exclude from analyses. Cancer Epidemiol Biomarkers Prev; 25(5); 823-9. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 26941367      PMCID: PMC4873428          DOI: 10.1158/1055-9965.EPI-15-1206

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

Authors:  S E Hankinson; W C Willett; J E Manson; G A Colditz; D J Hunter; D Spiegelman; R L Barbieri; F E Speizer
Journal:  J Natl Cancer Inst       Date:  1998-09-02       Impact factor: 13.506

2.  Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis.

Authors:  Cecilia Gälman; Bo Angelin; Mats Rudling
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

3.  [Seasonal change in blood concentration of uric acid and its potential clinical implications].

Authors:  J Murciano Revert; J J Martínez-Lahuerta; L Aleixandre Porcar
Journal:  Aten Primaria       Date:  2000-10-31       Impact factor: 1.137

4.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood.

Authors:  Peiyuan Yin; Andreas Peter; Holger Franken; Xinjie Zhao; Sabine S Neukamm; Lars Rosenbaum; Marianna Lucio; Andreas Zell; Hans-Ulrich Häring; Guowang Xu; Rainer Lehmann
Journal:  Clin Chem       Date:  2013-02-05       Impact factor: 8.327

Review 5.  Targeting bile-acid signalling for metabolic diseases.

Authors:  Charles Thomas; Roberto Pellicciari; Mark Pruzanski; Johan Auwerx; Kristina Schoonjans
Journal:  Nat Rev Drug Discov       Date:  2008-08       Impact factor: 84.694

6.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.

Authors:  Mary K Townsend; Clary B Clish; Peter Kraft; Chen Wu; Amanda L Souza; Amy A Deik; Shelley S Tworoger; Brian M Wolpin
Journal:  Clin Chem       Date:  2013-07-29       Impact factor: 8.327

7.  Metabolomics in epidemiology: sources of variability in metabolite measurements and implications.

Authors:  Joshua N Sampson; Simina M Boca; Xiao Ou Shu; Rachael Z Stolzenberg-Solomon; Charles E Matthews; Ann W Hsing; Yu Ting Tan; Bu-Tian Ji; Wong-Ho Chow; Qiuyin Cai; Da Ke Liu; Gong Yang; Yong Bing Xiang; Wei Zheng; Rashmi Sinha; Amanda J Cross; Steven C Moore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-08       Impact factor: 4.254

8.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling.

Authors:  Beate Kamlage; Sandra González Maldonado; Bianca Bethan; Erik Peter; Oliver Schmitz; Volker Liebenberg; Philipp Schatz
Journal:  Clin Chem       Date:  2013-12-04       Impact factor: 8.327

9.  Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach.

Authors:  Joo Ern Ang; Victoria Revell; Anuska Mann; Simone Mäntele; Daniella T Otway; Jonathan D Johnston; Alfred E Thumser; Debra J Skene; Florence Raynaud
Journal:  Chronobiol Int       Date:  2012-08       Impact factor: 2.877

10.  Effects of pre-analytical processes on blood samples used in metabolomics studies.

Authors:  Peiyuan Yin; Rainer Lehmann; Guowang Xu
Journal:  Anal Bioanal Chem       Date:  2015-03-04       Impact factor: 4.142

View more
  20 in total

1.  Quantitative metabolomics comparison of traditional blood draws and TAP capillary blood collection.

Authors:  Alexis Catala; Rachel Culp-Hill; Travis Nemkov; Angelo D'Alessandro
Journal:  Metabolomics       Date:  2018-07-12       Impact factor: 4.290

2.  Impact of post-collection freezing delay on the reliability of serum metabolomics in samples reflecting the California mid-term pregnancy biobank.

Authors:  Michael R La Frano; Suzan L Carmichael; Chen Ma; Macy Hardley; Tong Shen; Ron Wong; Lorenzo Rosales; Kamil Borkowski; Theresa L Pedersen; Gary M Shaw; David K Stevenson; Oliver Fiehn; John W Newman
Journal:  Metabolomics       Date:  2018-11-15       Impact factor: 4.290

Review 3.  Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions.

Authors:  Emma E McGee; Rama Kiblawi; Mary C Playdon; A Heather Eliassen
Journal:  Curr Nutr Rep       Date:  2019-09

4.  A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.

Authors:  Steven C Moore; Mary C Playdon; Joshua N Sampson; Robert N Hoover; Britton Trabert; Charles E Matthews; Regina G Ziegler
Journal:  J Natl Cancer Inst       Date:  2018-06-01       Impact factor: 13.506

5.  Presurgical blood metabolites and risk of postsurgical pelvic pain in young patients with endometriosis.

Authors:  Naoko Sasamoto; Oana A Zeleznik; Allison F Vitonis; Stacey A Missmer; Marc R Laufer; Julian Avila-Pacheco; Clary B Clish; Kathryn L Terry
Journal:  Fertil Steril       Date:  2022-03-30       Impact factor: 7.490

6.  Plasma Metabolomic Signature of Early Abuse in Middle-Aged Women.

Authors:  Tianyi Huang; Oana A Zeleznik; Andrea L Roberts; Raji Balasubramanian; Clary B Clish; A Heather Eliassen; Kathryn M Rexrode; Shelley S Tworoger; Susan E Hankinson; Karestan C Koenen; Laura D Kubzansky
Journal:  Psychosom Med       Date:  2022-04-27       Impact factor: 3.864

7.  Metabolomics to reveal biomarkers and pathways of preterm birth: a systematic review and epidemiologic perspective.

Authors:  R A Carter; K Pan; E W Harville; S McRitchie; S Sumner
Journal:  Metabolomics       Date:  2019-09-10       Impact factor: 4.290

Review 8.  Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation.

Authors:  Ernesto S Nakayasu; Marina Gritsenko; Paul D Piehowski; Yuqian Gao; Daniel J Orton; Athena A Schepmoes; Thomas L Fillmore; Brigitte I Frohnert; Marian Rewers; Jeffrey P Krischer; Charles Ansong; Astrid M Suchy-Dicey; Carmella Evans-Molina; Wei-Jun Qian; Bobbie-Jo M Webb-Robertson; Thomas O Metz
Journal:  Nat Protoc       Date:  2021-07-09       Impact factor: 17.021

9.  An Integrative Transcriptomic and Metabolomic Study of Lung Function in Children With Asthma.

Authors:  Rachel S Kelly; Bo L Chawes; Kevin Blighe; Yamini V Virkud; Damien C Croteau-Chonka; Michael J McGeachie; Clary B Clish; Kevin Bullock; Juan C Celedón; Scott T Weiss; Jessica A Lasky-Su
Journal:  Chest       Date:  2018-06-13       Impact factor: 9.410

10.  Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis.

Authors:  Éilis J O'Reilly; Kjetil Bjornevik; Jeremy D Furtado; Laurence N Kolonel; Loic Le Marchand; Marjorie L McCullough; Victoria L Stevens; Aladdin H Shadyab; Linda Snetselaar; JoAnn E Manson; Alberto Ascherio
Journal:  Neurology       Date:  2019-12-03       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.